EMA Authorised: Ritonavir Viatris (previously Ritonavir Mylan) (ritonavir) — Viatris Limited

View source ↗

Summary

The EMA authorised Ritonavir Viatris (ritonavir) for HIV infection, with Viatris Limited as the marketing authorization holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ritonavir Viatris (ritonavir)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Viatris Limited. Decision date: 18/03/2026